BridgeMD
Tests treatment safety and results for Bipolar Disorder (BD)
Official title Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
ClinicalTrials.gov ID: NCT07589647
What this study is testing
- What it's testing
- This study aims to stabilize the patients with bipolar disorder (BD) comorbid with obesity in the stable phase by using temporal interference stimulation (TIS ) intervention. It intends to investigate the changes in key metabolic molecules such as GLP-1 circadian rhythm, and further explore the molecular mechanism of their metabolic disorders.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Both biological parents are of Han ethnicity;
- Age range: 18 to 45 years old, gender not restricted;
- Meets the clinical diagnostic criteria for bipolar disorder as stipulated in the 5th edition of the Diagnostic and Statistical Manual of Mental...
- Body Mass Index (BMI) ≥ 28 kg/m2, or for males, waist circumference ≥ 90 cm and for females, waist circumference ≥ 85 cm;
- HAMD-24 score \< 7 points, YMRS score \< 5 points;
You likely can't join if
- 221/5000
- Individuals with other DSM-5 spectrum disorders;
- Mental disorders caused by substance abuse (such as alcohol, drugs, etc.), and those with severe physical illnesses;
- Those who consumed food or microecological preparations containing probiotics, prebiotics, etc. within one week before enrollment, and had a history...
- Those currently having serious suicidal thoughts or behaviors, or those with severe agitation;
- Those who cannot follow medical advice for treatment, or those without guardians;
See the full eligibility criteria
- Both biological parents are of Han ethnicity;
- Age range: 18 to 45 years old, gender not restricted;
- Meets the clinical diagnostic criteria for bipolar disorder as stipulated in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
- Body Mass Index (BMI) ≥ 28 kg/m2, or for males, waist circumference ≥ 90 cm and for females, waist circumference ≥ 85 cm;
- HAMD-24 score \< 7 points, YMRS score \< 5 points;
- All included researchers and their family members have given informed consent for this study.
- 221/5000
- Individuals with other DSM-5 spectrum disorders;
- Mental disorders caused by substance abuse (such as alcohol, drugs, etc.), and those with severe physical illnesses;
- Those who consumed food or microecological preparations containing probiotics, prebiotics, etc. within one week before enrollment, and had a history of respiratory, urinary, digestive system infections and antibiotic...
- Those currently having serious suicidal thoughts or behaviors, or those with severe agitation;
- Those who cannot follow medical advice for treatment, or those without guardians;
- Pregnant or lactating women, or those planning to become pregnant;
- Those who cannot complete MRI examinations due to special conditions such as having metal implants or pacemakers in their bodies.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.